From a Becker’s Hospital Review online release:
“This is the fourth time in the last two years we’ve had to activate our hospital’s emergency operations plan for a major drug shortage,” Dr. Biddinger told NBC News. “It’s almost unfathomable in modern medicine. I never thought we would get to a point in the U.S. healthcare system where we wouldn’t have essential medicines to be able to treat patients.”
Drug shortages are increasing and lasting longer, according to an FDA report published Oct. 29. Of 163 drugs running low in 2013-17, over 62 percent were due to manufacturing or product quality problems.
Hospitals nationwide are facing shortages of crucial, lifesaving drugs, with 116 drugs currently running low, according to the FDA and cited by NBC News.
Boston-based Massachusetts General Hospital is a prime example, getting as close as two weeks away from canceling a lifesaving cardiac surgery due to a lack of herapin, a blood-thinner, according to Paul Biddinger, MD, chief of the division of emergency preparedness at Massachusetts General Hospital.
“The results we saw were stunning and suggest that holistically addressing aging via gene therapy could be more effective than the piecemeal approach that currently exists,” said first author Noah Davidsohn, a former research scientist at the Wyss Institute and HMS who is now chief technology officer of Rejuvenate Bio. “Everyone wants to stay as healthy as possible for as long as possible, and this study is a first step toward reducing the suffering caused by debilitating diseases.”
Economists say aging baby boomers are the biggest culprits because many are staying healthier later in life and choosing not to downsize. Some look around at the lack of smaller, less expensive homes and are loath to get into bidding wars with their children’s generation to get one.
Measles is a dangerous infection that can kill. As many as 100,000 people die from the disease each year. For those who survive infection, the virus leaves a lasting mark—it appears to wipe out the immune system’s memory. News Intern Eva Fredrick joins host Sarah Crespi to talk about a pair of studies that looked at 
Washington Post columnist Ruth Marcus and syndicated columnist Michael Gerson join Amna Nawaz to analyze the week’s political news, including details emerging from witness depositions in the impeachment inquiry about President Trump’s dealings with Ukraine, current public opinion on Trump and impeachment and 2020 campaign updates, including the withdrawal of Democrat Beto O’Rourke.
Listen to the latest from the world of science, with Nick Howe and Shamini Bundell. This week, a milestone in quantum computing, and rethinking early mammals.
Listen to the latest from the world of science, with Benjamin Thompson and Shamini Bundell. This week, modelling embryonic development, and an analysis of male dominated conferences.
REV Ocean will be equipped for conducting missions that cover the entire marine ecosystem. It will be used by scientists and innovators for ‘solutions’ oriented research that explore issues such as the impact CO2 emissions have on the ocean, plastic pollution, and unsustainable fishing. REV Ocean will be an inclusive global vehicle for testing and proliferating ocean solutions. The vessel is 182.9 meters long and will have the capacity of holding 55 scientists and 35 crew. Equipment onboard includes scientific trawls, sonar systems, laboratories, auditorium and classrooms, moonpool, AUV and submarine, an ROV with 6000 meters depth capacity, and advanced communication equipment.
…of the top ten most desired locations to move to, the share of out-of-state searches on realtor.com ranges from 48% to 59.8%.
Boomers Daily 